Oxford Gene Technology, based in Begbroke, United Kingdom, specializes in providing advanced genetics research solutions to prominent clinical and academic institutions. The company offers a range of genomic technologies, including services for solid tumor panel and RNA sequencing, as well as gene expression analysis. These capabilities enable researchers to accurately identify the genetic variations that contribute to various diseases, thereby supporting advancements in the understanding and treatment of genetic conditions.
Sense Proteomic is discovers and commercializes autoantibody biomarkers for cancer and autoimmune diseases. It offers Kinome 2.0plus that is used by the pharmaceutical industry to screen kinase leads against human kinases. The company also provides biomarker panels for prostate cancer and lupus.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.